Comparison of bamlanivimab with or without etesevimab and casirivimab-imdevimab in clinical outcomes in patients with COVID-19: a systematic review and meta-analysis

J Chemother. 2024 May 9:1-3. doi: 10.1080/1120009X.2024.2352268. Online ahead of print.

Authors

Mingyang Yang^{1

2}, Junzhao Liu^{1

2}, Linna Luo^{1

2}, Kaili Dai^{1

2}

Affiliations

¹ Department of Emergency and Critical Care Medicine, West China School of Public Health, West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
² Health Emergency Management Research Center, China-PUMC C.C. Chen Institute of Health, Sichuan University.

PMID: 38721976
DOI: 10.1080/1120009X.2024.2352268

No abstract available